Japan Cancer Society

Recent papers from Japan Cancer Society

1. Burden of hospitalizations in four adolescent and young adult (AYA) cancer survivor populations in the United States, 2006-2020Cancer Epidemiology Biomarkers & Prevention · 2026
2. Changes in self-assessed infection prevention and control standards compliance following accreditation in palliative care services: A mixed-methods pre-post evaluationJournal of Infection Prevention · 2026
3. Improving Video‐Based Prediction of Cerebellar Ataxia Severity Using a Pretrained Deep Learning ModelBrain and Behavior · 2026
4. Osimertinib After Definitive Chemoradiotherapy in Unresectable Stage III EGFR-Mutated NSCLC: Subsequent Treatments and PPO From the Phase III LAURA StudyClinical Cancer Research · 2026
5. Association of Urinary pH With Overall Survival in Patients With Stage IV Cancer: A Single‐Center Retrospective Cohort StudyCancer Nexus · 2026
6. Association of alkalization therapy with long-term survival in stage IV or recurrent colorectal cancer: interaction with RAS mutation statusFrontiers in Oncology · 2026
7. Trastuzumab deruxtecan rechallenge in HER2-positive metastatic breast cancer: EN-SEMBLEThe Breast · 2026
8. Is Routine Interruption of Direct Oral Anticoagulants Necessary during Colorectal Endoscopic Mucosal Resection and Hot Snare Polypectomy? A Multicenter Propensity‐Matched StudyJournal of Gastroenterology and Hepatology · 2026
9. Medication‐Related Osteonecrosis of the Jaw Occurring During Cabozantinib Treatment for Renal Cell Carcinoma: A Report of Three CasesOral Science International · 2026
10. Cancer cachexia: a caregiver and advocate perspectiveCurrent Opinion in Supportive and Palliative Care · 2026
11. Impact of Thyroid Transcription Factor‐1 Expression on Outcomes of Platinum‐Based Chemoimmunotherapy in Advanced or Recurrent Non‐Squamous Non‐Small Cell Lung CancerThoracic Cancer · 2026
12. The European Multidisciplinary Evidence‐Based Guideline on Pancreatic Cancer: Methodological ProtocolClinical and Public Health Guidelines · 2026
13. A comparison of cisplatin plus S-1 versus mitomycin C, vindesine, and cisplatin in concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer: A target trial emulation study using a clinical trial databaseInternational Journal of Lung Cancer · 2026
14. Cancer recognition and assessment through non-invasive evaluation (CRANE): A prospective clinical validation study of a multi-biomarker class multi-cancer early detection (MCED) test in Japan.Journal of Clinical Oncology · 2026
15. Antiemetic Efficacy of Aprepitant in Cisplatin–Gemcitabine Therapy for Biliary Tract Cancer: A Multicenter StudyAnticancer Research · 2026
16. Online peer support for breast cancer survivors: A decentralized multicenter non-blinded parallel-group pilot randomized controlled trial (HOPE-BC study).Journal of Clinical Oncology · 2026
17. Trastuzumab deruxtecan (T-DXd) + bevacizumab (BEV) as first-line (1L) maintenance therapy in patients (pts) with human epidermal growth factor receptor 2 (HER2)–expressing ovarian cancer (OC): Results from the DESTINY-Ovarian01 (DO-01/ENGOT-ov89/GOG-3112/APGOT-OV13) safety run-in (SRI).Journal of Clinical Oncology · 2026
18. Real-world uptake of gBRCA testing as a companion diagnostic for olaparib in patients with high-risk HER2-negative early breast cancer in Japan: a cross-sectional multicenter study (BRCAwareness)Breast Cancer · 2026
19. Treatment and prognosis of subglottic cancers: a 10-year, multicenter, retrospective study in northern JapanOral Oncology · 2026
20. Five‐Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check‐Up Data in Japan: J‐GESS ScoreJournal of Gastroenterology and Hepatology · 2026